Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Platelet Transfusions in Hematopoietic Stem Cell Transplantation - The PATH Phase III Trial

NCT04448184 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.

NCT NCT04448184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04448184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Platelet Transfusions in Hematopoietic Stem Cell Transplantation - The PATH Phase III Trial
Lead sponsor
Ottawa Hospital Research Institute
Phase
Phase 3
Overall status
Recruiting
Start date
February 16, 2022
Completion date
February 28, 2027
Enrollment
662 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

hematologic neoplasms